À retenir
Among 3,932 English adults aged 60 and older, faster baseline walking speed was linked to lower dementia risk (HR 0.36), and a bigger drop in speed over two years to higher risk (HR 1.23). These are associations in an observational cohort, so slow walking may be an early sign of brain change rather than a cause of dementia.
Study design
Étude de cohorte
Reading basis
Published abstract
Reading focus
Association & confounding
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Slower walking often appears before memory problems, but it is unclear whether walking speed tells us something beyond what thinking tests already show. The authors tested whether walking speed and cognitive function, and changes in each over time, predict later dementia, and whether the two changes interact.
Population et méthode
Longitudinal observational study using the English Longitudinal Study of Ageing, with 3,932 community-dwelling participants aged 60 and older. Walking speed and cognition were measured at Wave 1 (2002-03) and Wave 2 (2004-05). New dementia cases were identified from Wave 3 (2006-07) to Wave 7 (2014-15). Associations were modelled with Cox proportional hazards regression. The abstract does not describe how dementia was ascertained or which confounders were adjusted for.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Faster baseline walking speed went with lower dementia risk: HR 0.36 (95% CI 0.22-0.60).
- 2A greater decline in walking speed between Wave 1 and Wave 2 went with higher risk: HR 1.23 (95% CI 1.03-1.47).
- 3Cognition showed the same pattern, and a stronger one for change: better baseline cognition HR 0.42 (95% CI 0.34-0.54); greater cognitive decline HR 1.78 (95% CI 1.53-2.06).
- 4Change in walking speed and change in cognition did not interact (HR 1.01, 95% CI 0.88-1.17), so the walking-speed link held independent of cognitive change.
Limites et incertitude
- 1Observational data cannot show that slower walking leads to dementia; undiagnosed early dementia could itself slow walking.
- 2Walking speed and cognition were compared over only one two-year interval (Wave 1 to Wave 2), a short window for judging decline.
- 3The abstract does not say how walking speed was measured or how dementia cases were confirmed, which affects how far the numbers can be trusted.
- 4The sample is community-dwelling English adults; results may not carry over to other populations. This reading is based on the abstract only.
Mise en perspective
Walking speed seems to carry information about future dementia risk alongside memory and thinking tests, and a noticeable slowing over time may be worth mentioning to a doctor. It does not show that walking faster would prevent dementia, and one slow day means little. Concerns about memory or mobility belong with your clinician.
Vos données
Wearables estimate gait speed from steps and stride, but the study used measured walking speed, so treat watch estimates as rough. If you track it, use the same device and a similar route or routine, and watch the trend over months rather than single readings.
Comprendre ce type de preuve
Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Objectives
To determine the relationships between walking speed, cognitive function, and the interaction between changes in these measures and dementia risk.
Design
Longitudinal observational study.
Setting
English Longitudinal Study of Ageing.
Participants
Individuals aged 60 and older (N=3,932).
Measurements
Walking speed and cognition were assessed at Waves 1 (2002-03) and 2 (2004-05) of the English Longitudinal Study of Ageing. New dementia cases were assessed from Wave 3 (2006-07) to Wave 7 (2014-15). The associations were modelled using Cox proportional hazards regression.
Results
Participants with faster baseline walking speeds were at lower risk of developing dementia (hazard ratio (HR)=0.36, 95% confidence interval (CI)=0.22-0.60). Those with a greater decline in walking speed from Wave 1 to 2 were at greater risk of developing dementia (HR=1.23, 95% CI=1.03-1.47). Participants with better baseline cognition (HR=0.42, 95% CI=0.34-0.54) were at lower risk of developing dementia. Those with a greater decline in cognition from Wave 1 to 2 were at greater risk of developing dementia (HR=1.78, 95% CI=1.53-2.06). Change in walking speed and change in cognition did not have an interactive effect on dementia risk (HR=1.01, 95% CI=0.88-1.17).
Conclusion
In this community-dwelling sample of English adults, those with slower walking speeds and a greater decline in speed over time were at greater risk of developing dementia independent of changes in cognition. Further research is required to understand the mechanisms that may drive these associations.
Sources et attribution
Walking Speed, Cognitive Function, and Dementia Risk in the English Longitudinal Study of Ageing.
Hackett RA, Davies-Kershaw H, Cadar D, Orrell M, Steptoe A.
Journal of the American Geriatrics Society · 2018-03-06
DOI: 10.1111/jgs.15312 ↗PubMed · 29508385 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Exercise gave small-to-moderate cognitive gains across 133 reviews of trials
An umbrella review of 133 systematic reviews (2724 trials, 258,279 participants) found that exercise improved general cognition (SMD 0.42, 95% CI 0.37 to 0.47), memory (0.26) and executive function (0.24), with the largest memory gains in children and adolescents and the largest executive function gains in people with ADHD. Most of the reviews (94) were rated critically low in quality and the effects were smaller in the best-rated ones (0.23 for general cognition), and the outcomes were test scores, not dementia.
British Journal of Sports Medicine
More daily steps linked to fewer depressive symptoms across 33 studies of adults
Pooling 33 observational studies of 96,173 adults, higher daily step counts went with fewer depressive symptoms, and in the two prospective cohorts that could be pooled, 7000 or more steps a day went with a lower risk of depression than fewer (RR 0.69, 95% CI 0.62-0.77). Most studies were cross-sectional, so low mood may be reducing steps as much as steps affect mood, and the authors say the prediction intervals call for caution.
JAMA Network Open
Exercise eased depression in 218 trials, but confidence in the evidence is low
In a network meta-analysis of 218 trials with 14,170 people who met criteria for major depression, walking or jogging, yoga, strength training, mixed aerobic exercise and tai chi or qigong each gave moderate reductions in depression compared with active controls (walking or jogging: Hedges' g −0.62, 95% credible interval −0.80 to −0.45). Confidence in the evidence was low for walking or jogging and very low for the other treatments, mainly because only one study met the low-risk-of-bias criteria.
BMJ
Physical activity eased depression and anxiety across 97 reviews of trials
Across 97 systematic reviews that pooled 1039 randomized trials with 128,119 participants, physical activity had medium effects on depression (median effect size −0.43) and anxiety (−0.42) compared with usual care, and higher-intensity activity went with larger gains. Most of those reviews (77) were rated critically low in quality, and the evidence mainly concerns mild-to-moderate symptoms.
British Journal of Sports Medicine

